PROLANZA olanzapine 15mg tablet blister pack

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

olanzapine, Quantity: 15 mg

Prieinama:

Medis Pharma Pty Ltd

INN (Tarptautinis Pavadinimas):

Olanzapine

Vaisto forma:

Tablet, film coated

Sudėtis:

Excipient Ingredients: microcrystalline cellulose; magnesium stearate; crospovidone; hyprolose; purified talc; lactose monohydrate; titanium dioxide; iron oxide yellow; xanthan gum; polyvinyl alcohol; iron oxide black; lecithin; indigo carmine aluminium lake

Vartojimo būdas:

Oral

Vienetai pakuotėje:

21, 60, 30, 7, 14, 28, 40, 10, 50, 20

Recepto tipas:

(S4) Prescription Only Medicine

Terapinės indikacijos:

For the treatment of schizophrenia and related psychoses. ,Alone or in combination with lithium or valproate, it is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. ,For preventing recurrence of manic, mixed or depressive episodes in Bipolar I Disorder.

Produkto santrauka:

Visual Identification: Light blue, oblong, biconvex film coated tablets; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Autorizacija statusas:

Registered

Leidimo data:

2011-08-11